Veradigm | MDRX - Stammkapital





Stammkapital Veränderung Datum
Alcidion AUD 1.34B 0 2025-12
Ambu A/S DKK 267.33M 941.07K 2026-06
Amplifon EUR 265.25M 45.3M 2026-06
Cardinal Health USD 233M 2M 2026-06
Centene USD 493.99M 216K 2026-06
Charles River Laboratories USD 47.73M 439K 2026-06
Cigna USD 264.6M 1.14M 2026-03
Coloplast 225.37M 0 2025-12
Convatec Group USD 251.5M 0 2024-12
CVS Health USD 1.28B 5M 2026-06
Elevance Health USD 216.84M 528K 2026-06
General Electric Aerospace USD 1.04B 5.77M 2026-06
Gulf Medical Proj AED 698.92M 0 2026-03
Humana USD 120.08M 18K 2026-06
IQVIA Holdings USD 164.6M 2.3M 2026-06
Laboratory Of America USD 80.9M 1.4M 2026-06
Maximus USD 52.36M 752K 2026-06
McKesson USD 116M 4M 2026-06
Med Life RON 530.82M 0 2026-03
Molina Healthcare USD 52M 0 2026-06
Omnicell USD 45.48M 2K 2026-06
Oriola-kd EUR 185.24M 0 2026-03
Owens Minor USD 76.39M 911K 2025-12
Quest Diagnostics USD 110M 1000K 2026-06
Rede D'or Sao Luiz BRL 2.18B 19M 2026-06
Siemens Healthineers EUR 1.12B 2.36M 2026-03
Sonova Holding CHF 59.61M 10.56K 2025-06
Supermax Corporation Bhd MYR 3.06B 0 2026-03
UnitedHealth USD 897.59M 10.55M 2026-09
Veeva Systems USD 162.44M 756K 2026-06
Veradigm USD 106.07M 103.28M 2022-12
Xerox USD 126M 2M 2025-03